title: Rectal indomethacin should be used routinely in all patients for prevention of post-ERCP pancreatitis.
authors.affiliation: Division of Gastroenterology, Department of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, USA.
authors.forename: Jodie A
authors.initials: JA
authors.lastname: Barkin
authors.affiliation: Division of Gastroenterology, Department of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, USA.
authors.forename: Enrico O
authors.initials: EO
authors.lastname: Souto
authors.affiliation: Division of Gastroenterology, Department of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, USA.
authors.forename: Jamie S
authors.initials: JS
authors.lastname: Barkin
mesh_terms: D000285:Administration, Rectal; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002760:Cholangiopancreatography, Endoscopic Retrograde; D006801:Humans; D007213:Indomethacin; D010195:Pancreatitis
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007213:Indomethacin